Downloads
Article: A New Breed Of Generics Company
By Dan Schell
I admit it — I was skeptical of the claims Alvogen was making. Prior to typing a single word on this two-year-old generics company, I encountered claims such as "creating the pharmaceutical company of tomorrow … ," "a radical new business model … ," and "Alvogen will be one of the world's 10 biggest generic drugmakers by revenues in five years." Further, in everything I read, vague terms such as "flexible," "strategic partnering," and "lean" kept popping up. I wanted clarification. I wanted to know if the company could live up to its marketing rhetoric. I wanted answers.
Used with permission from Life Science Leader magazine.
The content you requested is only available to registered users of Pharmaceutical Online. By registering now, you'll get access to this piece of content and thousands of additional articles and product reviews across our entire network of sites.
